Morley Fund Management is pleased to announce two appointments that initiate biotechnology/healthcare research, on both sides of the Atlantic. Richard Purkiss will be based in London and Henry Astarjian based in Boston. Both analysts will report to Donald Tosh, Head of Corporate Research.
Morley Fund Management is pleased to announce two appointments that initiate biotechnology/healthcare research, on both sides of the Atlantic. Richard Purkiss will be based in London and Henry Astarjian based in Boston. Both analysts will report to Donald Tosh, Head of Corporate Research.
Prior to joining Morley Fund Management, Richard Purkiss qualified in Medicine and completed a PhD from the UCL Medical School. Most recently he completed an M.B.A. at Imperial College. In the new role Richard will focus on the Pan-European biotechnology and healthcare sectors.
Henry Astarjian brings 15 years of investment experience to the role. Prior to joining the Boston office he worked for Fidelity and most recently, Gannett, Welsh & Kotler, a Boston based money manager. In his new role Henry will be a responsible for covering biotechnology and pharmaceutical industries, as well as other healthcare sectors.
Commenting on the appointments, Donald Tosh, Head of Corporate Research, said:
"These appointments, which build on our expanding analyst team, reflect our considerable commitment to research at Morley. Both Henry and Richard have extensive experience in the biotechnology/healthcare sector and will be valuable members of the team; we look forward to working with them."
Ends
For further information please contact
Morley Fund Management
Donald Tosh, Head of Corporate Research
020 7809 8209
Penrose Financial
Gay Collins/Caroline Deutsch - 020 7786 4888
gayc@penrose.co.uk
carolined@penrose.co.uk
Notes to Editors
Morley Fund Management is an independently managed, London based, asset management business with Ł106 billion under management. It has investment professionals based in Boston, Tokyo, Singapore and Dublin.
Morley is a wholly owned subsidiary of the CGNU Group and manages institutional funds under the Morley brand. It also acts as investment manager for a range of retail investment funds, marketed under the Norwich Union brand.
CGU plc and Norwich Union plc merged on 30 May 2000 to create CGNU plc, the UK's largest insurance group and one of the top-five insurers in Europe with substantial positions in other markets around the world, making it the world's sixth largest insurer based on gross worldwide premiums.
From October 2000, the combined life and pensions, general insurance and retail fund management businesses in the UK operate under the Norwich Union brand, while the institutional investment business operates under the Morley Fund Management brand.
Morley Fund Management is a business name of Morley Fund Management Limited (incorporated in England with Registered No. 1151805 and Registered Office 1 Poultry London EC2R 8EJ) and Norwich Union Investment Management Limited (incorporated in England with Registered No. 2152949 and Registered Office 8 Surrey Street Norwich NR1 3NG) both regulated by IMRO and members of the CGNU Group.